Review the safety and efficacy of vaccines under the condition of COVID-19 epidemic
4th International Conference on Frontiers of Biological Sciences and Engineering, FBSE 2021
; 2511, 2022.
Article
in English
| Scopus | ID: covidwho-1991750
ABSTRACT
SARS-Cov-2, a new strain of coronavirus that has never been found in humans before, has become one of the biggest public health issues in the 21st century. By March 2021, more than 100 million people around the world had been diagnosed with the disease. Confirmed cases of COVID-19 have ranged from mild symptoms to severe or even fatal. In the early stage of the disease, fever, fatigue, dry cough is the main clinical manifestations. About half of the patients developed dyspnea more than one week later, and the severe cases rapidly progressed to acute respiratory distress syndrome. Thus, the development of the COVID-19 vaccine is important because of the impact and damage caused by the virus worldwide. This paper will first introduce some information related to the vaccine, such as the safety and efficacy of the vaccine. Then, It will illustrate data on some COVID-19 vaccines that are on the market or still in development with comparison and analysis. © 2022 Author(s).
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Topics:
Vaccines
Language:
English
Journal:
4th International Conference on Frontiers of Biological Sciences and Engineering, FBSE 2021
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS